Diabetic retinopathy

J Fernando Arevalo, Andres F. Lasave, David G. Zeballos, Sergio Bonafonte-Roy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Diabetic retinopathy remains a major threat to sight in the working-age population in the developed world. In proliferative diabetic retinopathy (PDR), the growth of new vessels is thought to occur as a result of vascular endothelial growth factor (VEGF) release into the vitreous cavity as a response to ischemia, which facilitates the process of angiogenesis and macular edema. In these patients, the introduction of new therapies, such as VEGF inhibitors, may have a beneficial effect on diabetic retinopathy including diabetic macular edema and retinal neovascularization, and these therapies could complement laser photocoagulation treatment.

Original languageEnglish (US)
Title of host publicationRetinal and Choroidal Manifestations of Selected Systemic Diseases
PublisherSpringer New York
Pages387-416
Number of pages30
ISBN (Print)9781461436461, 9781461436454
DOIs
StatePublished - Jan 1 2013

Fingerprint

Diabetic Retinopathy
Macular Edema
Vascular Endothelial Growth Factor A
Retinal Neovascularization
Light Coagulation
Lasers
Therapeutics
Ischemia
Growth
Population

Keywords

  • Diffuse diabetic macular edema
  • Nonproliferative diabetic retinopathy
  • Proliferative diabetic retinopathy
  • Retinal photocoagulation
  • Tractional retinal detachment
  • Vascular endothelial growth factor
  • VEGF inhibitors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Arevalo, J. F., Lasave, A. F., Zeballos, D. G., & Bonafonte-Roy, S. (2013). Diabetic retinopathy. In Retinal and Choroidal Manifestations of Selected Systemic Diseases (pp. 387-416). Springer New York. https://doi.org/10.1007/978-1-4614-3646-1_21

Diabetic retinopathy. / Arevalo, J Fernando; Lasave, Andres F.; Zeballos, David G.; Bonafonte-Roy, Sergio.

Retinal and Choroidal Manifestations of Selected Systemic Diseases. Springer New York, 2013. p. 387-416.

Research output: Chapter in Book/Report/Conference proceedingChapter

Arevalo, JF, Lasave, AF, Zeballos, DG & Bonafonte-Roy, S 2013, Diabetic retinopathy. in Retinal and Choroidal Manifestations of Selected Systemic Diseases. Springer New York, pp. 387-416. https://doi.org/10.1007/978-1-4614-3646-1_21
Arevalo JF, Lasave AF, Zeballos DG, Bonafonte-Roy S. Diabetic retinopathy. In Retinal and Choroidal Manifestations of Selected Systemic Diseases. Springer New York. 2013. p. 387-416 https://doi.org/10.1007/978-1-4614-3646-1_21
Arevalo, J Fernando ; Lasave, Andres F. ; Zeballos, David G. ; Bonafonte-Roy, Sergio. / Diabetic retinopathy. Retinal and Choroidal Manifestations of Selected Systemic Diseases. Springer New York, 2013. pp. 387-416
@inbook{bb41311d7ae14f2b93b053f7532fbd8b,
title = "Diabetic retinopathy",
abstract = "Diabetic retinopathy remains a major threat to sight in the working-age population in the developed world. In proliferative diabetic retinopathy (PDR), the growth of new vessels is thought to occur as a result of vascular endothelial growth factor (VEGF) release into the vitreous cavity as a response to ischemia, which facilitates the process of angiogenesis and macular edema. In these patients, the introduction of new therapies, such as VEGF inhibitors, may have a beneficial effect on diabetic retinopathy including diabetic macular edema and retinal neovascularization, and these therapies could complement laser photocoagulation treatment.",
keywords = "Diffuse diabetic macular edema, Nonproliferative diabetic retinopathy, Proliferative diabetic retinopathy, Retinal photocoagulation, Tractional retinal detachment, Vascular endothelial growth factor, VEGF inhibitors",
author = "Arevalo, {J Fernando} and Lasave, {Andres F.} and Zeballos, {David G.} and Sergio Bonafonte-Roy",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-3646-1_21",
language = "English (US)",
isbn = "9781461436461",
pages = "387--416",
booktitle = "Retinal and Choroidal Manifestations of Selected Systemic Diseases",
publisher = "Springer New York",

}

TY - CHAP

T1 - Diabetic retinopathy

AU - Arevalo, J Fernando

AU - Lasave, Andres F.

AU - Zeballos, David G.

AU - Bonafonte-Roy, Sergio

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Diabetic retinopathy remains a major threat to sight in the working-age population in the developed world. In proliferative diabetic retinopathy (PDR), the growth of new vessels is thought to occur as a result of vascular endothelial growth factor (VEGF) release into the vitreous cavity as a response to ischemia, which facilitates the process of angiogenesis and macular edema. In these patients, the introduction of new therapies, such as VEGF inhibitors, may have a beneficial effect on diabetic retinopathy including diabetic macular edema and retinal neovascularization, and these therapies could complement laser photocoagulation treatment.

AB - Diabetic retinopathy remains a major threat to sight in the working-age population in the developed world. In proliferative diabetic retinopathy (PDR), the growth of new vessels is thought to occur as a result of vascular endothelial growth factor (VEGF) release into the vitreous cavity as a response to ischemia, which facilitates the process of angiogenesis and macular edema. In these patients, the introduction of new therapies, such as VEGF inhibitors, may have a beneficial effect on diabetic retinopathy including diabetic macular edema and retinal neovascularization, and these therapies could complement laser photocoagulation treatment.

KW - Diffuse diabetic macular edema

KW - Nonproliferative diabetic retinopathy

KW - Proliferative diabetic retinopathy

KW - Retinal photocoagulation

KW - Tractional retinal detachment

KW - Vascular endothelial growth factor

KW - VEGF inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84949008716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949008716&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3646-1_21

DO - 10.1007/978-1-4614-3646-1_21

M3 - Chapter

AN - SCOPUS:84949008716

SN - 9781461436461

SN - 9781461436454

SP - 387

EP - 416

BT - Retinal and Choroidal Manifestations of Selected Systemic Diseases

PB - Springer New York

ER -